Treatment Information

Back

Bladder Cancer treatment details. Chemotherapy.

Stanford University School of Medicine, Stanford, CA, United States.

Survival: monthsCountry:United States
Toxiciy Grade:3City/State/Province:Stanford, CA
Treatments:ChemotherapyHospital:Stanford University School of Medicine
Drugs:Journal:Link
Date:Jul 2009

Description:

Patients:
This phase 2 study involved 11 metastatic urothelial carcinoma patients who had been previously treated with platinum-based chemotherapy. The median patient age was 65 years and 9 were male.

Treatment:
Patients were treated with the chemotherapy agents docetaxel and oxaliplatin.

Toxicities:
The most severe toxicities were of grade 3 and included diarrhea. Grade 1 fatigue and nerve disorders were also reported.

Results:
The median overall survival was 7 months.

Support:
This study was supported by Sanofi-Aventis.

Correspondence: Dr. Sandy Srinivas; email: [email protected]



Back